Abstract: 249
Key points
• Coxiella burnetii is associated with an increased risk of lymphoma, its presence in the tumor microenvironment may favor lymphomagenesis.
• Lymphoma has to be considered in patients with Q fever and lymphoid disorders, especially those with persistent focalized infections.
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ABSTRACT
Bacteria can induce human lymphomas, while lymphoproliferative disorders have been described in patients with Q fever. We observed a lymphoma in a patient with Q fever that prompted us to investigate the association between the two diseases. We screened 1, 468 consecutive patients of the 2004-2014 French National Referral Center for Q fever database.
The standardized incidence ratios (SIR) of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) were calculated comparatively to the 2012 Francim registry. The presence of Coxiella burnetii was tested using immunofluorescence and fluorescence in situ hybridization using a specific 16S rRNA probe and genomic DNA probe. Seven patients For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From
INTRODUCTION
The incidence of non-Hodgkin lymphoma (NHL) is increasing in many regions making it a global health challenge for the coming years and is still associated with significant mortality. 1, 2 Risk factors include mainly infection, immunosuppression (HIV, organ-transplant recipients, high-dose chemotherapy, stem-cell transplantation and inherited immunodeficiency syndromes) or autoimmune diseases. 1, 3, 4 Recent data from the InterLymph consortium reported that some risk factors such as family history of NHL are common among NHL subtypes whereas others such as HIV or hepatitis C seropositivity appeared to be distinct among individuals or a few subtypes. 4 Hereditary factors 5 supporting a genetic predisposition include tumor necrosis factor (TNF) and interleukin-10 (IL10) polymorphisms, 6 suggesting that these pro-or anti-inflammatory cytokines are critical in NHL physiopathology. 4 Besides viruses, bacterial infections play a role in the development of some B-cell NHL, either by inhibition of immune function or by induction of chronic inflammatory response. 1 Helicobacter pylori is associated with gastric B-cell lymphoma, 7 Campylobacter jejuni with immunoproliferative small intestinal disease, 8 Borrelia burgdorferi with cutaneous B-cell lymphoma, 9 and Chlamydia psittaci with ocular adnexal lymphoma.
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Q fever is a zoonosis caused by the intracellular bacterium Coxiella burnetii. 11 The primary infection, symptomatic in 10-60% of cases (then called acute Q fever), usually resolves spontaneously in a few weeks. In less than 5% of cases, the infection persists mainly as endocarditis or vascular infection. 11 Persistent lymphadenitis has also been reported with detection of the bacterium in the excised lymph node (supplemental Table 1 Table 2 ). Lymphoma, however, was previously considered to be a risk factor of persistent Q fever rather than a consequence of the infection. 23, 24 We previously reported a case of Q fever vascular infection revealed by an aortoenteric fistula. 25 This patient, while improving under antibiotics, developed lymphadenitis near the site of infection, corresponding to a follicular B-cell lymphoma (FL). C. burnetii was identified in the lymphoma tissue sample by fluorescent in situ hybridization (FISH). This index case prompted us to i) collect cases of patients developing lymphoma after C. burnetii primary infection in order to assess a possible excess risk of B-cell lymphoma in Q fever patients, ii) to test the presence of the bacterium in lymphoma biopsies, iii) to evaluate the IL10 production in Q fever patients with lymphoma and iv) to investigate whether patients with persistent focalized infection were more at risk of lymphoma than acute Q fever patients.
METHODS

French National Referral center for Q Fever cohort
The French National Referral center for Q Fever cohort database includes all patients with a possible or definite C. burnetii infection diagnosed since 2004 in our center. Patients are included in the database if they are screened positive for C. burnetii in case of specific demand or syndromic diagnosis (blood culture-negative endocarditis, pericarditis, uveitis and central nervous system infection) and systematically on the following biopsies (osteoarticular samples, lymph nodes, skin samples, pharyngeal swabs, cardiac valve and vascular samples).
Moreover, C. burnetii is also systematically sought for in all sera sent for Bartonella, Rickettsia, Francisella, Anaplasma and Ehrlichia testing. Table 3 ). Clinical data are systematically collected for positive patients over the phone and added to our computerized database.
Diagnosis of C. burnetii infection
Serology and molecular detection of C. burnetii have been performed as previously described. 27 targeting the genomic sequences of C. burnetii were generated by indirect labeling of the DNA with fluorescent dyes (ARES DNA labeling, Molecular Probes, Eugene, Oregon). The slides were blocked in 3% BSA in PBS-0.1% Tween 20 before IF using primary antibodies (supplemental Table 4 Molecular Devices, Sunnyvale, CA, USA), and confocal analysis was performed using a Leica TCS 4DA confocal microscope. The method used to quantify the immune cell subset infected by C. burnetii is detailed in the supplemental data. Twenty-two lymphoma samples from patients without Q fever were included as controls (supplemental Table 5 ).
Cytokine measurements
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From IL10 amount in sera was determined using specific immunoassays (R&D Systems) according to the manufacturer's recommendations. IL10 and TNF were measured in supernatants from non-stimulated and C. burnetii stimulated peripheral blood mononuclear cells (PBMC) as previously described. 35 
Statistical analysis
The incidence rate and its 95% confidence interval (CI) were computed for cases of DLBCL occurring during follow-up in the study population diagnosed between 2004 and 2014 (N=1,468) at the French national reference center of Q fever. Patients were enrolled between January 2004 and December 2014, and they were followed up at most until the end of March 2015, which was used as censoring date. The person-years for the Q fever database were calculated as the total sum of the number of years between Q fever diagnosis of each patient and either his lymphoma diagnosis or his last available follow-up record or the censoring date.
To confirm the significant elevation of the risk of DLBCL and FL in patients with Q fever compared with the French general population, we computed the standardized incidence ratios (SIR) 36 and their 95% confidence intervals, taking into account the difference in age-gender distribution between the Q fever cohort and the general population. The data for the general population were extracted from the Francim national registry reporting the estimation of the incidence of cancers in France in 2012. 2 Comorbidities and immunodeficiency were not adjusted for as they were not mentioned in this report. A Cox proportional-hazards regression model was used to estimate the strength of the association between C. burnetii persistent focalized infection and occurrence of lymphoma. A sensitivity analysis was performed by removing from the dataset those patients who experienced both acute Q fever and persistent focalized infections to verify the robustness of the results. The Stata/SE 12.1 software (StataCorp LP, College Station, USA) was used for these analyses.
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Ethical considerations
The study was approved by the local ethics committee (Comité de Protection des Personnes Sud Mediterranée 1) under registration number 1355 and by the French National Drugs and Health Products Agency. All patients gave informed consent, in accordance with the Declaration of Helsinki.
RESULTS
Index case
In August 2011, a 78-year-old man presented with Q fever abdominal aortic vascular infection complicated by an aorto-enteric fistula. 25 C. burnetii was isolated from the resected vascular material by culture, polymerase chain reaction (PCR) and genome sequencing. Six months later, F 18 fluorodeoxyglucose positron emission tomography identified a latero-aortic mass close to the infected focus with strong hypermetabolic uptake and several mesenteric lymph nodes. One year later, while the infection had improved clinically and serologically, these anomalies worsened (supplemental Figure 1I ,II,III) such that a CT-scan-guided biopsy targeting the latero-aortic mass close to the vascular infected site (supplemental Figure 1II) identified a low-grade follicular B-cell lymphoma with FISH detection of C. burnetii in CD68 + macrophages.
Frequency of lymphoma among Q fever patients
Between 2004 and 2014, 93,166 individuals were tested for C. burnetii in our center. 91,628
individuals had negative serology and were not included in our cohort database ( Figure 1 ).
The age/gender distribution of these patients assessed but who were determined not to have Q fever was (mean ± standard deviation) 52.3 years (20.8 years) including 48,241 men (52.6%), 1 1 respectively. Among the 1,538 individuals from our cohort database, 70 were excluded after detailed medical records analysis ( Figure 1 ) so that 1,468 individuals were considered infected with a mean age of 50.50 ± 17.07 years and involving 998 men (68%). Patients infected were significantly younger (two-tailed t-test, P < 0.0001) and more frequently male (two-tailed Chi-squared test, P < .0001) than patients assessed but who were determined not to have Q fever and not included in the parent database. Among the 1,468 patients included, 1,028 (70%) had an acute Q fever without progression to persistent focalized infection and 440 (30%) had a persistent focalized infection including 68 (4.6%) with initial acute Q fever.
Among the 1,468 Q fever patients, we found seven (0.48%) patients including the index case with a diagnosis of lymphoma after C. burnetii primary infection.
Increased incidence of DLBCL and FL in Q fever patients compared to the general population
Overall, DLBCB was found in six out of the 1,468 screened Q fever patients. 
Clinicopathological characteristics
Among the seven patients analyzed, the mean age (±SD) All seven patients presented mature B-cell NHL, 37 including six DLBCL (supplemental Figure 3) and one low-grade (1-2) FL. All patients presented elevated LDH and Beta-2 microglobulin at lymphoma diagnosis. Ann Arbor staging at diagnosis was III in 2 patients and IV in 5 patients. Bcl-2 and Bcl-6 translocations were detected in two patients.
EBV was negative in all lymphoma tissue samples. Details about DLBCL subtyping, and clinical treatment and outcome are provided in supplemental Methods & supplemental Figure   4 , and supplemental Table 6 , respectively. Table 5 ).
C. burnetii is present in both macrophages
We investigated the cellular compartment harboring C. burnetii using a combination of double staining and computerized microscopic analysis (supplemental Table 8 ). Since the distribution of the infected cells within an individual tumor was heterogeneous, the or immunohistochemistry (4 samples) in the 3 FISH-negative samples.
As a control, we tested 3 patients with Q fever lymphadenitis but without lymphoma. C. burnetii was detected in several CD68 + cells in 2 patients. In contrast to lymphoma samples, CD123 + pDCs cells were rare and none of them were infected (supplemental Figure 6 ). Altogether these findings suggest a specific pDCs localization of C.
burnetii in the microenvironment of lymphomas occurring in the setting of C. burnetii infection.
Interleukin-10 production in Q fever patients with lymphoma
Interleukin-10 (IL10) was tested as a putative instrumental cytokine in 386 sera from 79 patients and was found to be highly elevated in patients with lymphoma (median 25. Among Q fever patients, those with lymphoma have very significantly higher IL10 levels than Figure 8 ).
Risk factors of lymphoma among Q fever patients
Comparing Q fever patients with lymphoma, patients with lymphadenitis who did not develop lymphoma and other Q fever patients (Table 2) , we found that persistent focalized infection was a risk factor for lymphadenitis (Odds ratio, 1.78; 95% CI, 1.04-3.03; P = .047) but to a lesser extent than for lymphoma (OR, 14.54; 95% CI, 2.14-337.7; P = .007). Indeed, patients with persistent focalized infections were more likely to develop lymphoma (6/440 (1.4%)) than acute Q fever patients without known progression to persistent focalized infection . 2 This size effect is unlikely to be attributable to plausible confounding 38 as it was adjusted for age and sex, and is far greater than the mean annual increase incidence The specific pDC infection and increased IL10 levels in patients with Q feverassociated lymphoma suggest an alteration of the immune signals within the lymphoma microenvironment. IL10 was previously shown to be a B-cell growth factor with immunosuppressive properties that up-regulates bcl-2 expression. 6 Viral IL10 is critical for Bcell transformation and proliferation by EBV. 42, 43 High IL10 levels were found in the sera of NHL patients [44] [45] [46] [47] and were associated with poor prognosis. 44;45;48-51 In Q fever, overproduction of IL10 by infected monocytes is critical in sustaining replication of the bacterium, and is associated with an inhibition of the microbicidal activity of macrophages.
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IL10 serum levels are increased in acute Q fever patients with valvulopathy and in endocarditis, and persistent elevated IL10 levels are predictive of relapse.
A putative scenario could be proposed in which C. burnetii-infected monocytes and pDCs induce impairment of the immune system favoring lymphoma occurrence. In primary or 1 6 persistent Q fever, infected monocytes migrate via lymphatic vessels to the lymph nodes. The influence of the lymph node microenvironment, including apoptotic lymphocytes from germinal centers, may induce a specific polarization of the monocytes/macrophages towards an M2 profile, characterized by a higher production of anti-inflammatory cytokines and IL10. 53 Our observation of intermediate IL10 levels in C. burnetii related lymphadenitis, which occurs more frequently in the setting of persistent infection, suggests that it might represent a pre-lymphoma condition. Infection of pDCs may represent a critical step towards lymphomagenesis as these cells were not infected in patients with lymphadenitis. Infected pDCs can also induce an increase in IL10 secretion via type 1 interferon production 54 and upregulation of inducible co-stimulating ligand expression. 55 Thus, monocytes and plasmacytoid dendritic cells are probably both responsible for the impairment of the immune system. IL10 in turn stimulates the replication of C. burnetii in monocytes 56 and prevents apoptosis of germinal center B cells by overexpression of the Bcl-2 protein. 57 IL10-mediated immune impairment may be favorable to both C. burnetii replication and lymphoma growth.
Our observation of bcl-2 and bcl-6 rearrangements suggests that the early steps of lymphomagenesis may be shared in Q fever patients and in the general population. This hypothesis is also consistent with the localization of C. burnetii in the micro-environment but not in the neoplastic cells. Of note, the presence of C. burnetii in lymphoma tissues cannot be explained by a clinical setting of immunosuppression in our patients. The absence of EBV in C. burnetii infected tumors also argues against a pre-existing immunosuppression that could have favoured C. burnetii persistence in the tumor microenvironment.
The InterLymph consortium reported that risk factors of lymphoid neoplasms are related to either specific NHL subtypes or to virtually all lymphomas. 4, 37 Considering the 7 included cases (Table 1 ) and 4 additional cases from France, Spain and Israel (supplemental Table 6 ), we found 6 DLBCL, 2 FL, 2 marginal zone lymphomas and 1 lymphoplasmocytic Table 2 ). Altogether, the 16 clinical cases of Q fever associated lymphoproliferative lesions reported in the present work and in the literature correspond to mature B-cell neoplasms. 37 Larger series are needed to confirm that the risk of lymphoma occurrence in Q fever patients does not involve precursor lymphoid neoplasms nor T-cell lymphomas.
General farm worker was identified by the InterLymph consortium as an independent risk factor affecting overall NHL risk 4 and particularly hairy cell leukemia. 58 On the other hand, occupation as a farmer is the main risk factor for Q fever, associated with hairy cell leukemia in the literature. 19, 21, 22 Altogether these findings suggest that C. burnetii infection could be responsible, at least in part, for the excess risk of NHL in farm workers.
While our data are supportive of an association between C. burnetii and B-cell NHL, other lymphoma risk factors could not be excluded. Indeed, this was a retrospective study and some factors like family history of hematologic malignancy were not collected. 4 Future prospective studies are needed to confirm the accurate incidence rate, as our cohort possibly suffered from center bias that probably tends to overestimate incidence. Conversely, the incidence may have been underestimated as the Q fever-lymphoma association was unknown, so that some lymphoma cases possibly diagnosed several months to years after Q fever may have been missed.
For the first time in the literature, we provide evidence that C. burnetii may be a lymphoma cofactor. This confirms other abundant data linking this bacterium to lymphoproliferative disorders (supplemental Table 2 ) including very recent reports from the Dutch outbreak. 22 Although we cannot conclude that Q fever directly causes lymphoma, our results are unlikely to be due to chance since several criteria for causation are fulfilled. 38, 59 Additional reports of cases treated by antibiotics alone would provide greater support for the 1 8 purported association. Disregarding the causality issue, the link between Q fever and lymphoma that we evidence herein should not been neglected since early diagnosis of lymphoma would result in improved outcomes of Q fever patients. 1 Moreover, the management of patients with B-cell NHL would be improved by the detection of C. burnetii infection in endemic areas.
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Figure 2. Interleukin 10 levels in Q fever patients
Interleukin-10 was evaluated in 397 sera including 24 sera from 5 patients with lymphoma, 250 sera from 48 patients with lymphadenitis, 112 sera from 26 patients with acute Q fever without valvulopathy and without progression to persistent focalized infection and 11 healthy controls. Median and interquartile range. The horizontal line corresponds to the maximum level observed in 11 healthy controls (12pg/ml). *P < .05, ***P < .0005, ****P < .00005.
Bilateral Mann-Whitney test. A gradient was observed suggesting that patients with lymphadenitis without lymphoma may represent a pre-lymphoma condition.
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